Monopar Therapeutics Inc. Share Price
MNPR$44.09
+$6.48 (17.24%) Last updated on 06 Sep, 2025 | 01:29 ISTMonopar Therapeutics Inc. Stock Performance
Open $39.09 | Prev. Close $37.61 | Circuit Range N/A |
Day Range $38.80 - $43.43 | Year Range $2.29 - $54.30 | Volume 982 |
Average Traded $40.34 |
Monopar Therapeutics Inc. Share Price Chart
About Monopar Therapeutics Inc.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Monopar Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Sep-25 | $39.09 | $43.43 | +15.47% |
04-Sep-25 | $36.99 | $37.61 | +2.09% |
03-Sep-25 | $36.33 | $36.84 | +8.16% |
29-Aug-25 | $33.87 | $34.06 | -4.35% |
28-Aug-25 | $35.60 | $35.61 | +2.28% |
27-Aug-25 | $34.30 | $34.81 | +9.45% |
26-Aug-25 | $30.30 | $31.81 | +8.86% |
FAQs on Monopar Therapeutics Inc. Share Price
Can I buy Monopar Therapeutics Inc. shares in India?
What is the share price of Monopar Therapeutics Inc.?
What is the 5 year returns of Monopar Therapeutics Inc.?
What are the high & low stock price of Monopar Therapeutics Inc. today?
What is the 52-week high and low of Monopar Therapeutics Inc. stock?